Price target
34.080.00 0.00%
The 6 analysts offering 1 year price forecasts for 603233 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to 603233 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
603233 EPS for the last quarter is 0.23 CNY despite the estimation of 0.22 CNY. In the next quarter EPS is expected to reach 0.11 CNY. Track more of DASHENLIN PHARMACEUTICAL GROUP financials and stay on top of what is up with the company.
In the next quarter DASHENLIN PHARMACEUTICAL GROUP revenue is expected to reach 6.77 B CNY. Check out DASHENLIN PHARMACEUTICAL GROUP revenue and earnings and make informed decisions.
According to analysts, 603233 price target is 34.08 CNY with a max estimate of 38.00 CNY and a min estimate of 28.90 CNY. Check if this forecast comes true in a year, meanwhile keep track of the current situation with 603233 news and stock market news.
We've gathered opinions of 7 analysts rating 603233 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.